Quantitative Flow Ratio for Assessment of Non-Culprit Coronary Artery Lesions During Percutaneous Coronary Intervention (PCI) in 79 Patients Diagnosed with ST-Elevation Myocardial Infarction (STEMI): A Study from a Single Center in Lithuania

立陶宛单中心研究:经皮冠状动脉介入治疗(PCI)中,79例ST段抬高型心肌梗死(STEMI)患者非罪犯冠状动脉病变的定量血流比值评估

阅读:1

Abstract

BACKGROUND Approximately half of the patients requiring percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) have additional stenotic coronary artery (CA) lesions in non-infarct-related arteries (non-IRA). This study from a single center in Lithuania aimed to evaluate the use of the quantitative flow ratio (QFR) in assessing non-IRA lesions during PCI in 79 patients diagnosed with STEMI. MATERIAL AND METHODS We prospectively included 105 vessels of 79 patients with worldwide STEMI criteria and ≥1 intermediate (35-75%) lesion in non-IRA between July 2020 and June 2021. For all included patients, QFR analyses were performed twice, during the index PCI (QFR 1) and during a staged procedure ≥3 months later (QFR 2). The QFR analyses were performed with the QAngio-XA 3D and £0.80 were used as cut-off values for PCI. The primary endpoint was a head-to-head numerical agreement between 2 measurements. RESULTS An excellent numerical agreement was found in all investigated lesions, r=0.931, p<0.001, left anterior descending (LAD) r=0.911, p<0.001, left circumflex (LCx) r=0.977, p<0.001, and right coronary artery (RCA) 0.946, p<0.001. Clinical treatment decision-making showed amazing agreement between the 1st and the 2nd QFR analyses, r=0.980, p<0.001. There was 1 disagreement between QFR 1 and QFR 2. CONCLUSIONS The findings from this support previous studies and showed that the QFR is a practical quantitative method to evaluate non-IRA lesions, which in this study included STEMI patients during PCI following occlusive CA stenosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。